BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 1684468)

  • 21. T-cell receptor excision circles (TREC) in CD4+ and CD8+ T-cell subpopulations in atopic dermatitis and psoriasis show major differences in the emission of recent thymic emigrants.
    Just HL; Deleuran M; Vestergaard C; Deleuran B; Thestrup-Pedersen K
    Acta Derm Venereol; 2008; 88(6):566-72. PubMed ID: 19002340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitation of canine regulatory T cell populations, serum interleukin-10 and allergen-specific IgE concentrations in healthy control dogs and canine atopic dermatitis patients receiving allergen-specific immunotherapy.
    Keppel KE; Campbell KL; Zuckermann FA; Greeley EA; Schaeffer DJ; Husmann RJ
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):337-44. PubMed ID: 18423890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated serum levels of APRIL, but not BAFF, in patients with atopic dermatitis.
    Matsushita T; Fujimoto M; Echigo T; Matsushita Y; Shimada Y; Hasegawa M; Takehara K; Sato S
    Exp Dermatol; 2008 Mar; 17(3):197-202. PubMed ID: 17979975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating activated T lymphocytes in autoeczematization.
    Kasteler JS; Petersen MJ; Vance JE; Zone JJ
    Arch Dermatol; 1992 Jun; 128(6):795-8. PubMed ID: 1599265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of CD25hiCD4+ "regulatory" T-cell subtypes in atopic dermatitis reveals a novel T(H)2-like population.
    Reefer AJ; Satinover SM; Solga MD; Lannigan JA; Nguyen JT; Wilson BB; Woodfolk JA
    J Allergy Clin Immunol; 2008 Feb; 121(2):415-422.e3. PubMed ID: 18177697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between serum levels of interleukin-18, IgE and disease severity in patients with atopic dermatitis.
    Trzeciak M; Gleń J; Bandurski T; Sokołowska-Wojdyło M; Wilkowska A; Roszkiewicz J
    Clin Exp Dermatol; 2011 Oct; 36(7):728-32. PubMed ID: 21689145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An in vitro study of IgE production in severe atopic dermatitis.
    Hovmark A
    Acta Derm Venereol; 1979; 59(3):223-7. PubMed ID: 87079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum levels of soluble interleukin-2 receptor in patients with perennial allergic rhinitis before and after immunotherapy.
    Ohashi Y; Nakai Y; Sakamoto H; Ohno Y; Sugiura Y; Okamoto H; Tanaka A; Kakinoki Y; Kishimoto K; Hayashi M
    Ann Allergy Asthma Immunol; 1996 Sep; 77(3):203-8. PubMed ID: 8814045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome.
    Wakim M; Alazard M; Yajima A; Speights D; Saxon A; Stiehm ER
    Ann Allergy Asthma Immunol; 1998 Aug; 81(2):153-8. PubMed ID: 9723561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between serum IL-16 levels and the degree of sensitization in patients with atopic dermatitis.
    Nagy G; Gáspár K; Irinyi B; Gál M; Tumpek J; Gyimesi E; Sipka S; Remenyik É; Szodoray P; Szegedi A
    Int Arch Allergy Immunol; 2011; 156(1):69-74. PubMed ID: 21447961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An in vitro study of depressed cell-mediated immunity and of T and B lymphocytes in atopic dermatitis.
    Hovmark A
    Acta Derm Venereol; 1977; 57(3):237-42. PubMed ID: 71829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The chemotactic activity of T-lymphocytes in response to interleukin 8 is significantly decreased in patients with psoriasis and atopic dermatitis.
    Zheng M; Sun G; Mrowietz U
    Exp Dermatol; 1996 Dec; 5(6):334-40. PubMed ID: 9028795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential cytokine profiles in peripheral blood lymphocyte supernatants and skin biopsies from patients with different forms of atopic dermatitis, psoriasis and normal individuals.
    Kägi MK; Wüthrich B; Montano E; Barandun J; Blaser K; Walker C
    Int Arch Allergy Immunol; 1994; 103(4):332-40. PubMed ID: 8130648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral natural killer cells exhibit qualitative and quantitative changes in patients with psoriasis and atopic dermatitis.
    Luci C; Gaudy-Marqueste C; Rouzaire P; Audonnet S; Cognet C; Hennino A; Nicolas JF; Grob JJ; Tomasello E
    Br J Dermatol; 2012 Apr; 166(4):789-96. PubMed ID: 22233261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased serum levels of interleukin 33 in patients with atopic dermatitis.
    Tamagawa-Mineoka R; Okuzawa Y; Masuda K; Katoh N
    J Am Acad Dermatol; 2014 May; 70(5):882-8. PubMed ID: 24569114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis.
    Mashiko S; Bouguermouh S; Rubio M; Baba N; Bissonnette R; Sarfati M
    J Allergy Clin Immunol; 2015 Aug; 136(2):351-9.e1. PubMed ID: 25792465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered production of immuno-modulating cytokines in patients with atopic dermatitis.
    Kapp A; Kirnbauer R; Luger TA; Schöpf E
    Acta Derm Venereol Suppl (Stockh); 1989; 144():97-9. PubMed ID: 2800914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum IgE in dermatitis and dermatosis: an analysis of 497 cases.
    O'Loughlin S; Diaz-Perez JL; Gleich GJ; Winkelmann RK
    Arch Dermatol; 1977 Mar; 113(3):309-15. PubMed ID: 139128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum levels of soluble interleukin-2 receptor (sIL-2R) in B-chronic lymphocytic leukemia.
    Cacciola E; Calogero D; Marra G; Guglielmo P
    Boll Soc Ital Biol Sper; 1992 Apr; 68(4):259-62. PubMed ID: 1463600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin 6 and 8 levels in plasma and fibroblast cultures in psoriasis.
    Zalewska A; Głowacka E; Wyczółkowska J; Tchórzewski H; Narbutt J; Sysa-Jedrzejowska A
    Mediators Inflamm; 2006; 2006(1):81767. PubMed ID: 16864908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.